The Role of Hnrnps in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Hnrnps in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Acta Neuropathologica https://doi.org/10.1007/s00401-020-02203-0 REVIEW The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis Alexander Bampton1,2 · Lauren M. Gittings3 · Pietro Fratta4 · Tammaryn Lashley1,2 · Ariana Gatt1,2 Received: 25 June 2020 / Revised: 27 July 2020 / Accepted: 27 July 2020 © The Author(s) 2020 Abstract Dysregulated RNA metabolism is emerging as a crucially important mechanism underpinning the pathogenesis of fron- totemporal dementia (FTD) and the clinically, genetically and pathologically overlapping disorder of amyotrophic lateral sclerosis (ALS). Heterogeneous nuclear ribonucleoproteins (hnRNPs) comprise a family of RNA-binding proteins with diverse, multi-functional roles across all aspects of mRNA processing. The role of these proteins in neurodegeneration is far from understood. Here, we review some of the unifying mechanisms by which hnRNPs have been directly or indirectly linked with FTD/ALS pathogenesis, including their incorporation into pathological inclusions and their best-known roles in pre-mRNA splicing regulation. We also discuss the broader functionalities of hnRNPs including their roles in cryptic exon repression, stress granule assembly and in co-ordinating the DNA damage response, which are all emerging patho- genic themes in both diseases. We then present an integrated model that depicts how a broad-ranging network of pathogenic events can arise from declining levels of functional hnRNPs that are inadequately compensated for by autoregulatory means. Finally, we provide a comprehensive overview of the most functionally relevant cellular roles, in the context of FTD/ALS pathogenesis, for hnRNPs A1-U. Keywords hnRNP · Frontotemporal dementia · Amyotrophic lateral sclerosis · RNA · Autoregulation Introduction RNA and protein homeostasis have been identifed as con- verging mechanisms of neurotoxicity in both disorders. Frontotemporal lobar degeneration (FTLD) is an umbrella RNA-binding proteins (RBPs) play a central role in regulat- pathological term that encompasses a group of heterogene- ing all aspects of gene expression, hence their dysfunction is ous neurodegenerative disorders known to cause frontotem- likely to be a key contributing feature of disrupted RNA and poral dementia (FTD) [108]. FTLD is believed to lie on a protein homeostasis in these diseases [118]. The heterogene- single disease continuum with the neuromuscular disease ous nuclear ribonucleoprotein (hnRNP) family is a family amyotrophic lateral sclerosis (ALS) [52]. Indeed, disrupted of RBPs containing one or more RNA-binding domains that facilitate their extensive and divergent functionality across all stages of nucleic acid metabolism [59]. More recently, Tammaryn Lashley and Ariana Gatt: Joint senior authors. hnRNPs have also been shown to play a role in the orches- tration of the DNA damage in response to genotoxicity and * Tammaryn Lashley [email protected] assembly of stress granules in response to other cellular stresses. Here, we review some of the common themes by 1 The Queen Square Brain Bank for Neurological Disorders, which hnRNPs function to maintain homeostasis within cells Department of Clinical and Movement Neuroscience, UCL and, by extension, highlight potentially vulnerable pathways Queen Square Institute of Neurology, London, UK by which neurotoxicity can be induced or exacerbated fol- 2 Department of Neurodegenerative Diseases, UCL Queen lowing their dysregulation during FTLD/ALS pathogenesis. Square Institute of Neurology, London, UK 3 Department of Neurobiology, Barrow Neurological Institute, 350 W Thomas Road, Phoenix, AZ 85013, USA 4 Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK Vol.:(0123456789)1 3 Acta Neuropathologica Structure and function of hnRNP proteins on its own. Whilst others can override potential export signals to prevent shuttling and promote complete nuclear Early studies using nucleoplasm immunopurifications retention [148]. reported three novel hnRNPs (A, B, C) to be highly Functionally, hnRNP proteins have been implicated at all abundant polypeptide components of mRNA-bound com- stages of mRNA maturation including transcriptional regu- plexes [32, 163]. The hnRNP family has since expanded lation, capping, alternative splicing, polyadenylation, trans- to include at least twenty other closely related and ubiqui- port and stability [49]. HnRNP localisation is predominantly tously expressed RBPs named alphabetically from hnRNP nuclear, however, several hnRNPs can shuttle between the A1 to hnRNP U [49] (Table 1). Structurally, hnRNPs are nucleus and the cytoplasm to regulate additional cytoplas- best defned by their modular structure consisting of one mic functions such as mRNA nucleocytoplasmic transport or more RNA-binding domains (Fig. 1). These domains, and translation [134]. Indeed, hnRNPs form highly dynamic which include the most frequently found RNA-recogni- complexes with RNA and other RBPs to regulate these pro- tion motif (RRM), K homology (KH) domain and RGG cesses. They are able to successfully associate and interact box motif, confer hnRNPs with the ability to bind a large with an array of diferent mRNA processing machinery by number of RNA targets, within a vast RNA-binding inter- virtue of constant remodelling of their mRNA-protein com- actome. Notably, as with other RBPs, hnRNPs can also plex compositions [48]. Hence, hnRNPs bind RNA in a com- bind RNA through their intrinsically disordered regions binatorial arrangement according to their relative afnities (IDRs) or low complexity domains (LCDs) as they are for specifc sequence elements and their relative abundances more commonly referred. These are regions of low amino in a spatial and temporal manner [48, 80]. The uniquely acid complexity which facilitates the formation of higher- assembled constellation of potentially synergistic or antago- order ribonucleoprotein complexes via LCD-driven phase nistically acting hnRNPs may in-turn enhance or suppress separation [20, 74]. Hence, whilst hnRNPs can interact the recruitment of further RBPs to the complex which ulti- with RNA binding partners in a sequence-specifc manner, mately dictates its precise functionality. Post-translational nonspecifc interactions are also prevalent among hnRNPs modifcations are also likely to modulate hnRNP functioning consistent with their observed overlapping, as well as dis- in diferent cellular contexts which represents another layer tinct functionalities [27]. Several hnRNPs also contain of regulatory control over an extensive hnRNP protein-RNA nuclear localisation sequences to ensure a predominantly network [74]. nuclear subcellular localisation or nuclear export signals Notably, despite their many structural and functional sim- which mediates their shuttling to and from the cytoplasm. ilarities, the distinction of hnRNP proteins from other RBPs Intriguingly, some nuclear localisation sequences (e.g., including SR splicing factors and messenger RNPs (mRNPs) m9) can also serve as a bi-directional import/export signal proteins is largely a historic one based on old nomencla- ture [48]. Indeed, the well characterised TAR DNA binding Table 1 The hnRNP family and their common aliases HnRNP protein Alternative protein names A1, A2/B1, A3, A/B hnRNP A1; hnRNP A2/B1; HnRNP A3, HNRPA3; hnRNP A/B, ABBP-1 C hnRNP C, hnRNP C1/C2 D (D0, DL) hnRNP D0, AUF1; hnRNP D-like, laAUF1, JKT41-binding protein E (E1, E2) hnRNP E1, PCBP1, Alpha-CP1; hnRNP E2, PCBP2, Alpha-CP2 F hnRNP F, nucleolin-like protein mcs94-1 G hnRNP G, RNA-binding motif protein, X chromosome (RBMX), Glycoprotein p43 H (H1, H2, H3) hnRNP H1; hnRNP H2, FTP-3, hnRNP H’; hnRNP H3, hnRNP 2H9 I hnRNP I, PTB, PPTB-1 K hnRNP K, TUNP L (L, LL) hnRNP L; hnRNP LL, SRRF M hnRNP M P hnRNP P, FUS, 75 kDA DNA-pairing protein, oncogene TLS, POMp75 Q hnRNP Q, SYNCRIP, GRY-RBP, NS1-associated protein R hnRNP R U hnRNP U, GRIP120, SAF-A, Nuclear p120 ribonucleoprotein Each hnRNP protein’s most commonly used protein name is highlighted in bold text 1 3 Acta Neuropathologica Fig. 1 The hnRNP family: composition and structure. The hnRNP tifed domain in this category. Several hnRNPs also possess a nuclear family are named alphabetically from A1 to U, with hnRNP U being import/export signal to enable them to perform both nuclear and the largest protein (120 kDa) in the class. The proteins all contain cytoplasmic functions. RRM RNA recognition motif, KH K-homol- varying combinations and quantities of RNA-binding domains which ogy domain, RGG Arg-Gly-Gly repeat domain, NLS nuclear locali- facilitate their myriad functional roles in pre-mRNA processing. sation signal. Number in the bottom right corner of each schematic RNA-recognition motifs (RRMs) are by far the most commonly iden- indicates amino acid length 1 3 Acta Neuropathologica protein 43 (TDP-43) is frequently categorised as a member classical inclusions but also pathologies associated with the of the hnRNP family but is not named as such due to being C9orf72 expansion mutation, as reviewed below. missed by the initial 2-dimensional gel and immunopurifca- tion experiments. For reasons of clarity and conciseness we TDP‑43 and FUS pathologies focus the second half of this review on the original hnRNP (A1-U) proteins, noting that more recently added members TDP-43 and FUS are probably the most well-known hnRNPs of the hnRNP family, including TDP-43, have been reviewed in the feld of neurodegeneration. Their accumulation in extensively elsewhere [90, 110]. pathological inclusions
Recommended publications
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • Stroke Genetics and Genomics
    Faculdade de Medicina da Universidade de Lisboa Unidade Neurológica de Investigação Clínica PhD Thesis Stroke Genetics and Genomics Tiago Krug Coelho Host Institution: Instituto Gulbenkian de Ciência Supervisor at Instituto Gulbenkian de Ciência: Doctor Sofia Oliveira Supervisor at Faculdade de Medicina da Universidade de Lisboa: Professor José Ferro PhD in Biomedical Sciences Specialization in Neurosciences 2010 Stroke Genetics and Genomics A ciência tem, de facto, um único objectivo: a verdade. Não esgota perfeitamente a sua tarefa se não descobre a causa do todo. Chiara Lubich i Stroke Genetics and Genomics ii Stroke Genetics and Genomics A impressão desta dissertação foi aprovada pela Comissão Coordenadora do Conselho Científico da Faculdade de Medicina de Lisboa em reunião de 28 de Setembro de 2010. iii Stroke Genetics and Genomics iv Stroke Genetics and Genomics As opiniões expressas são da exclusiva responsabilidade do seu autor. v Stroke Genetics and Genomics vi Stroke Genetics and Genomics Abstract ABSTRACT This project presents a comprehensive approach to the identification of new genes that influence the risk for developing stroke. Stroke is the leading cause of death in Portugal and the third leading cause of death in the developed world. It is even more disabling than lethal, and the persistent neurological impairment and physical disability caused by stroke have a very high socioeconomic cost. Moreover, the number of affected individuals is expected to increase with the current aging of the population. Stroke is a “brain attack” cutting off vital blood and oxygen to the brain cells and it is a complex disease resulting from environmental and genetic factors.
    [Show full text]
  • Genetically Modified Macrophages and Renal Regeneration
    Genetically Modified Macrophages and Renal Regeneration Chrysoula Mastora ADVERTIMENT. La consulta d’aquesta tesi queda condicionada a l’acceptació de les següents condicions d'ús: La difusió d’aquesta tesi per mitjà del servei TDX (www.tdx.cat) i a través del Dipòsit Digital de la UB (diposit.ub.edu) ha estat autoritzada pels titulars dels drets de propietat intel·lectual únicament per a usos privats emmarcats en activitats d’investigació i docència. No s’autoritza la seva reproducció amb finalitats de lucre ni la seva difusió i posada a disposició des d’un lloc aliè al servei TDX ni al Dipòsit Digital de la UB. No s’autoritza la presentació del seu contingut en una finestra o marc aliè a TDX o al Dipòsit Digital de la UB (framing). Aquesta reserva de drets afecta tant al resum de presentació de la tesi com als seus continguts. En la utilització o cita de parts de la tesi és obligat indicar el nom de la persona autora. ADVERTENCIA. La consulta de esta tesis queda condicionada a la aceptación de las siguientes condiciones de uso: La difusión de esta tesis por medio del servicio TDR (www.tdx.cat) y a través del Repositorio Digital de la UB (diposit.ub.edu) ha sido autorizada por los titulares de los derechos de propiedad intelectual únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con finalidades de lucro ni su difusión y puesta a disposición desde un sitio ajeno al servicio TDR o al Repositorio Digital de la UB.
    [Show full text]
  • Supplementary Table 1 Genes Tested in Qrt-PCR in Nfpas
    Supplementary Table 1 Genes tested in qRT-PCR in NFPAs Gene Bank accession Gene Description number ABI assay ID a disintegrin-like and metalloprotease with thrombospondin type 1 motif 7 ADAMTS7 NM_014272.3 Hs00276223_m1 Rho guanine nucleotide exchange factor (GEF) 3 ARHGEF3 NM_019555.1 Hs00219609_m1 BCL2-associated X protein BAX NM_004324 House design Bcl-2 binding component 3 BBC3 NM_014417.2 Hs00248075_m1 B-cell CLL/lymphoma 2 BCL2 NM_000633 House design Bone morphogenetic protein 7 BMP7 NM_001719.1 Hs00233476_m1 CCAAT/enhancer binding protein (C/EBP), alpha CEBPA NM_004364.2 Hs00269972_s1 coxsackie virus and adenovirus receptor CXADR NM_001338.3 Hs00154661_m1 Homo sapiens Dicer1, Dcr-1 homolog (Drosophila) (DICER1) DICER1 NM_177438.1 Hs00229023_m1 Homo sapiens dystonin DST NM_015548.2 Hs00156137_m1 fms-related tyrosine kinase 3 FLT3 NM_004119.1 Hs00174690_m1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 GRIN1 NM_000832.4 Hs00609557_m1 high-mobility group box 1 HMGB1 NM_002128.3 Hs01923466_g1 heterogeneous nuclear ribonucleoprotein U HNRPU NM_004501.3 Hs00244919_m1 insulin-like growth factor binding protein 5 IGFBP5 NM_000599.2 Hs00181213_m1 latent transforming growth factor beta binding protein 4 LTBP4 NM_001042544.1 Hs00186025_m1 microtubule-associated protein 1 light chain 3 beta MAP1LC3B NM_022818.3 Hs00797944_s1 matrix metallopeptidase 17 MMP17 NM_016155.4 Hs01108847_m1 myosin VA MYO5A NM_000259.1 Hs00165309_m1 Homo sapiens nuclear factor (erythroid-derived 2)-like 1 NFE2L1 NM_003204.1 Hs00231457_m1 oxoglutarate (alpha-ketoglutarate)
    [Show full text]
  • Highly Conserved Syntenic Blocks at the Vertebrate Hox Loci and Conserved Regulatory Elements Within and Outside Hox Gene Clusters
    Highly conserved syntenic blocks at the vertebrate Hox loci and conserved regulatory elements within and outside Hox gene clusters Alison P. Lee, Esther G. L. Koh, Alice Tay, Sydney Brenner†, and Byrappa Venkatesh† Institute of Molecular and Cell Biology, 61 Biopolis Drive, Singapore 138673 Contributed by Sydney Brenner, February 22, 2006 Hox genes in vertebrates are clustered, and the organization of the Another factor that may have contributed to the clustering and clusters has been highly conserved during evolution. The conser- colinearity of Hox genes is the existence of global enhancers that vation of Hox clusters has been attributed to enhancers located regulate several genes in a manner independent of their local within and outside the Hox clusters that are essential for the enhancers but dependent on their location in the cluster. Global coordinated ‘‘temporal’’ and ‘‘spatial’’ expression patterns of Hox control regions (GCRs) have been identified on either side of the genes in developing embryos. To identify evolutionarily conserved HoxD cluster. The 5Ј HoxD GCR, regulating the expression of regulatory elements within and outside the Hox clusters, we Lnp, Evx2, and posterior HoxD genes in developing digits and the obtained contiguous sequences for the conserved syntenic blocks central nervous system, is located Ϸ240 kb upstream of HoxD13 from the seven Hox loci in fugu and carried out a systematic search in the intergenic region between Atp5g3 and Lnp (3). The 3Ј for conserved noncoding sequences (CNS) in the human, mouse, HoxD GCR mapped downstream of HoxD1, called early limb and fugu Hox loci. Our analysis has uncovered unusually large control region, is implicated in the early colinear expression of conserved syntenic blocks at the HoxA and HoxD loci.
    [Show full text]
  • Host Cell Factors Necessary for Influenza a Infection: Meta-Analysis of Genome Wide Studies
    Host Cell Factors Necessary for Influenza A Infection: Meta-Analysis of Genome Wide Studies Juliana S. Capitanio and Richard W. Wozniak Department of Cell Biology, Faculty of Medicine and Dentistry, University of Alberta Abstract: The Influenza A virus belongs to the Orthomyxoviridae family. Influenza virus infection occurs yearly in all countries of the world. It usually kills between 250,000 and 500,000 people and causes severe illness in millions more. Over the last century alone we have seen 3 global influenza pandemics. The great human and financial cost of this disease has made it the second most studied virus today, behind HIV. Recently, several genome-wide RNA interference studies have focused on identifying host molecules that participate in Influen- za infection. We used nine of these studies for this meta-analysis. Even though the overlap among genes identified in multiple screens was small, network analysis indicates that similar protein complexes and biological functions of the host were present. As a result, several host gene complexes important for the Influenza virus life cycle were identified. The biological function and the relevance of each identified protein complex in the Influenza virus life cycle is further detailed in this paper. Background and PA bound to the viral genome via nucleoprotein (NP). The viral core is enveloped by a lipid membrane derived from Influenza virus the host cell. The viral protein M1 underlies the membrane and anchors NEP/NS2. Hemagglutinin (HA), neuraminidase Viruses are the simplest life form on earth. They parasite host (NA), and M2 proteins are inserted into the envelope, facing organisms and subvert the host cellular machinery for differ- the viral exterior.
    [Show full text]
  • Comparative Gene Expression Analysis of Blood and Brain Provides Concurrent Validation of SELENBP1 Up-Regulation in Schizophrenia
    Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia Stephen J. Glatta,b,c,d, Ian P. Everallb,c,e, William S. Kremena,c, Jacques Corbeilf,g, Roman Saˇ ´ sˇikh, Negar Khanlouc,e, Mark Hani, Choong-Chin Liewi, and Ming T. Tsuanga,c,j,k,l aCenter for Behavioral Genomics, Departments of cPsychiatry and gMedicine, hUniversity of California San Diego Cancer Center, and eHIV Neurobehavioral Research Center, University of California at San Diego, La Jolla, CA 92093; dVeterans Medical Research Foundation, San Diego, CA 92161; fDepartment of Anatomy and Physiology, Laval University, Quebec, PQ, Canada G1V 4G2; iChondroGene, Inc., Toronto, ON, Canada M3J 3K4; jDepartments of Epidemiology and Psychiatry, Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA 02115; and kVeterans Affairs Healthcare System, San Diego, CA 92161 Communicated by Eric R. Kandel, Columbia University, New York, NY, September 1, 2005 (received for review July 28, 2005) Microarray techniques hold great promise for identifying risk come under study. Because gene expression can reflect both genetic factors for schizophrenia (SZ) but have not yet generated widely and environmental influences, it may be particularly useful for reproducible results due to methodological differences between identifying risk factors for a complex disorder such as SZ, which is studies and the high risk of type I inferential errors. Here we thought to have a multifactorial polygenic etiology in which many established a protocol for conservative analysis and interpretation genes and environmental factors interact. However, the simulta- of gene expression data from the dorsolateral prefrontal cortex of neous consideration of thousands of dependent variables also SZ patients using statistical and bioinformatic methods that limit increases the likelihood of false-positive results (7).
    [Show full text]
  • Oligonucleotide Microarray Analysis of Distinct Gene Expression Patterns in Colorectal Cancer Tissues Harboring BRAF and K-Ras Mutations
    Carcinogenesis vol.27 no.3 pp.392–404, 2006 doi:10.1093/carcin/bgi237 Advance Access publication October 11, 2005 Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations Il-Jin Kim1,y, Hio Chung Kang1,2,y, Sang-Geun Jang1, Introduction Kun Kim1, Sun-A Ahn1, Hyun-Ju Yoon1, Sang Nam Yoon3 and Jae-Gahb Park1,2,3,Ã Colorectal cancer (CRC) is an important human cancer, and incidence rates of this cancer are increasing in Asian countries 1 Korean Hereditary Tumor Registry, Cancer Research Institute and such as Korea (1). CRC development is a multi-step process Downloaded from https://academic.oup.com/carcin/article/27/3/392/2476120 by guest on 27 September 2021 Cancer Research Center, Seoul National University, Seoul, Korea, (2) involving microsatellite instability (MSI), mutations in 2Research Institute and Hospital, National Cancer Center, 809 Madu-dong, Ilsan-gu, Goyang, Gyeonggi 411-764, Korea mismatch repair (MMR) of genes such as MLH1 and MSH2, and 3Department of Surgery, Seoul National University College of and mutations in APC, SMAD4,K-ras, TP53 and b-catenin Medicine, Seoul, Korea (2–9). Somatic BRAF mutations have been reported in ÃTo whom correspondence should be addressed. 5.1–18% of CRCs (10–12). BRAF is one of three serine/ E-mail: [email protected] threonine kinases (ARAF, BRAF, CRAF/RAF1) that act within Various types of human cancers harbor BRAF somatic the RAS–RAF–MEK–ERK–MAPK signaling pathway (13). mutations, leading researchers to seek molecular targets BRAF mutations have also been reported in 80% of primary for BRAF inhibitors.
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • Mouse Hnrnpa3 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Hnrnpa3 Knockout Project (CRISPR/Cas9) Objective: To create a Hnrnpa3 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Hnrnpa3 gene (NCBI Reference Sequence: NM_146130 ; Ensembl: ENSMUSG00000059005 ) is located on Mouse chromosome 2. 11 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 10 (Transcript: ENSMUST00000111964). Exon 2~8 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 starts from about 6.42% of the coding region. Exon 2~8 covers 78.45% of the coding region. The size of effective KO region: ~2249 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 7 8 11 Legends Exon of mouse Hnrnpa3 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 1313 bp section downstream of Exon 8 is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Cervix Cancer
    Microarrays 2015, 4, 287-310; doi:10.3390/microarrays4020287 OPEN ACCESS microarrays ISSN 2076-3905 www.mdpi.com/journal/microarrays Article An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer Enery Lorenzo 1, Katia Camacho-Caceres 1, Alexander J. Ropelewski 2, Juan Rosas 1, Michael Ortiz-Mojer 1, Lynn Perez-Marty 1, Juan Irizarry 1, Valerie Gonzalez 1, Jesús A. Rodríguez 1, Mauricio Cabrera-Rios 1 and Clara Isaza 1,3,* 1 Bio IE Lab, The Applied Optimization Group at UPRM, Industrial Engineering Department, University of Puerto Rico at Mayaguez, Call Box 9000, Mayagüez, PR 00681, USA; E-Mails: [email protected] (E.L.); [email protected] (K.C.-C.); [email protected] (J.R.); [email protected] (M.O.-M.); [email protected] (J.I.); [email protected] (V.G.); [email protected] (J.A.R.); [email protected] (M.C.-R.) 2 Pittsburgh Supercomputing Center, 300 S. Craig Street, Pittsburgh, PA 15213, USA; E-Mail: [email protected] 3 Department of Pharmacology and Toxicology, Ponce School of Medicine, PO Box 700, Ponce, PR 00732, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-787-840-2575 (ext. 2198). Academic Editor: Shu-Kay Ng Received: 22 February 2015 / Accepted: 13 May 2015 / Published: 28 May 2015 Abstract: Establishing how a series of potentially important genes might relate to each other is relevant to understand the origin and evolution of illnesses, such as cancer. High-throughput biological experiments have played a critical role in providing information in this regard.
    [Show full text]
  • Transcriptome Characterization of Human Mammary Cell Lines Expressing Different Levels of ERBB2 by Serial Analysis of Gene Expression
    1441-1461 26/4/06 13:24 Page 1441 INTERNATIONAL JOURNAL OF ONCOLOGY 28: 1441-1461, 2006 Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression MARIANA LOPES DOS SANTOS1, CAROLINA GONÇALVES PALANCH1, SIBELI SALAORNI1, WILSON ARAUJO DA SILVA Jr2 and MARIA APARECIDA NAGAI1 1Disciplina de Oncologia, Departamento de Radiologia da Faculdade de Medicina da Universidade de São Paulo, São Paulo; 2Departamento de Genética, Faculdade de Medicina de Ribeirão Preto-USP, Ribeirão Preto, Brazil Received October 31, 2005; Accepted December 27, 2005 Abstract. Over-expression of ERBB2, a member of the family Introduction of transmembrane receptor tyrosine kinases, occurs in 15-30% of primary breast tumors and is associated with poor prognosis The ERBB2 gene, also known as HER2/NEU, encodes a and chemoresistance to a variety of anticancer drugs. In this 185-kDa transmembrane glycoprotein with intrinsic tyrosine study, aiming to identify differentially-expressed genes kinase activity that belongs to the epidermal growth factor involved in erbB2-mediated transformation of the breast, we receptor (EGFR) family (1). This family of receptor tyrosine generated SAGE libraries from two human mammary cell kinases (RTKs) comprises four members, EGFR (ERBB1), lines, derived from normal luminal cells, expressing different ERBB2 (HER2), ERBB3 and ERBB4 that play important roles levels of erbB2. The parental cell line HB4a expresses basal in several signal transduction pathways regulating cell prolifer- levels and the C5.2 expresses high levels of erbB2. A total of ation, differentiation, cytoskeletal rearrangement and survival 161,632 tags was generated by sequencing, 81,684 from HB4a (1,2).
    [Show full text]